(183682, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003089', 'decreased skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183683, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021009', 'abnormal synaptic physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183684, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183685, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010073', 'decreased pruritus', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183686, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004245', 'genital hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183687, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183688, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183689, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001927', 'abnormal estrous cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183690, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183691, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002193', 'minimal clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183692, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183693, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013500', 'abnormal fibroblast apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183694, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183695, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003997', 'tonic-clonic seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183696, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005025', 'abnormal response to infection', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183697, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004994', 'abnormal brain wave pattern', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183698, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183699, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011432', 'decreased urine flow rate', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183700, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005167', 'abnormal blood-brain barrier function', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183701, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001844', 'autoimmune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183702, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008407', 'decreased cellular sensitivity to hydrogen peroxide', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183703, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005140', 'decreased cardiac muscle contractility', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183704, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183705, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006053', 'hypothalamus hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183706, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008667', 'decreased interleukin-12a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183707, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183708, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001953', 'respiratory failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183709, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008009', 'delayed cellular replicative senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183710, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010756', 'decreased right ventricle peak pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183711, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008055', 'increased urine osmolality', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183712, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183713, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006058', 'decreased cerebral infarct size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183714, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013284', 'abnormal renal glomerular filtration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183715, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001935', 'decreased litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183716, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183717, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006336', 'abnormal otoacoustic response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183718, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004814', 'reduced linear vestibular evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183719, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004010', 'increased diastolic filling velocity', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183720, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000533', 'kidney hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183721, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031223', 'increased CXCL10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183722, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008699', 'increased interleukin-4 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183723, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031434', 'increased miscarriage rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183724, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183725, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183726, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010554', 'shortened HV interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183727, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001922', 'reduced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183728, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020218', 'abnormal tear production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183729, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008776', 'increased right ventricle peak pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183730, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011043', 'abnormal lung elastance', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183731, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183732, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003474', 'abnormal summary potential intensity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183733, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004085', 'abnormal heartbeat', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183734, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009643', 'abnormal urine homeostasis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183735, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000423', 'delayed hair regrowth', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183736, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009687', 'empty decidua capsularis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183737, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009348', 'abnormal urine pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183738, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002064', 'seizures', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183739, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003635', 'abnormal synaptic transmission', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183740, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009473', 'abnormal skin exfoliation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183741, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183742, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000327', 'hemosiderinuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183743, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183744, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003589', 'abnormal ureter physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183745, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020418', 'increased cardiac muscle relaxation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183746, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003787', 'abnormal imprinting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183747, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183748, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008702', 'increased interleukin-5 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183749, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012553', 'decreased serum complement activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183750, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000313', 'abnormal cell death', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183751, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010553', 'prolonged HV interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183752, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183753, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001984', 'abnormal olfaction', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183754, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001854', 'atrial endocarditis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183755, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183756, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000921', 'demyelination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183757, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183758, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011418', 'leukocyturia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183759, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183760, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183761, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183762, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031136', 'muscle hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183763, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020040', 'decreased bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183764, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183765, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183766, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031423', 'abnormal luteolysis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183767, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183768, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013305', 'isosthenuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183769, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001986', 'abnormal taste sensitivity', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183770, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020000', 'abnormal response to antigen', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183771, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183772, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183773, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012033', 'abnormal ERG implicit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183774, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183775, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010393', 'shortened QRS complex duration', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183776, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008817', 'hematoma', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183777, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001634', 'internal hemorrhage', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183778, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011399', 'increased endoneurial fluid pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183779, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012046', 'decreased susceptibility to hypertension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183780, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010505', 'abnormal T wave', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183781, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183782, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004149', 'increased bone strength', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183783, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183784, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009350', 'decreased urine pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183785, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183786, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011811', 'decreased anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183787, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183788, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183789, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183790, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008145', 'hemeralopia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183791, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002292', 'abnormal gestational length', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183792, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002893', 'ketoaciduria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183793, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004039', 'abnormal cardiac cell glucose uptake', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183794, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014252', 'abnormal paired-pulse ratio', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183795, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183796, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006203', 'eye hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183797, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013625', 'increased femur yield load', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183798, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021055', 'decreased renal arterial blood pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183799, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020080', 'increased bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183800, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008744', 'abnormal B cell anergy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183801, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003091', 'abnormal cell migration', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183802, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003897', 'abnormal ST segment', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183803, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003039', 'increased time of peak ischemic contracture', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183804, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002418', 'increased susceptibility to viral infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183805, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001633', 'poor circulation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183806, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004144', 'hypotonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183807, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008664', 'decreased interleukin-12 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183808, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031088', 'coughing', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183809, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183810, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010822', 'pneumothorax', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183811, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003375', 'abnormal menstrual cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183812, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005599', 'increased cardiac muscle contractility', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183813, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003882', 'abnormal pulse pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183814, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008660', 'increased interleukin-10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183815, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004744', 'reduced vestibular evoked myogenic potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183816, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011923', 'abnormal bladder urine volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183817, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183818, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008703', 'decreased interleukin-5 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183819, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183820, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031479', 'increased urine xanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183821, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012034', 'abnormal a-wave shape', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183822, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003292', 'melena', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183823, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011931', 'abnormal pulmonary valve flow', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183824, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183825, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183826, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010509', 'decreased P wave amplitude', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183827, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031109', 'subarachnoid hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183828, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010519', 'atrioventricular block', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183829, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001926', 'female infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183830, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031470', 'abnormal macropinocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183831, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014274', 'decreased respiration', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183832, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002333', 'abnormal lung compliance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183833, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009732', 'ventricular premature beat', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183834, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183835, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006043', 'decreased apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183836, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183837, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004120', 'cardiac ischemia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183838, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001596', 'hypotension', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183839, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183840, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005529', 'abnormal renal vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183841, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183842, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001727', 'abnormal embryo implantation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183843, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005275', 'abnormal skin tensile strength', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183844, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000250', 'abnormal vasoconstriction', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183845, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020845', 'abnormal DNA-templated transcription', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183846, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005330', 'cardiomyopathy', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183847, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011926', 'abnormal heart valve physiology', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183848, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006266', 'decreased pulse pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183849, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008705', 'increased interleukin-6 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183850, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005410', 'abnormal fertilization', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183851, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003186', 'abnormal redox activity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183852, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183853, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000060', 'delayed bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183854, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009010', 'abnormal diestrus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183855, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005001', 'abnormal clonal deletion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183856, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183857, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013135', 'poor circulation in tail', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183858, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011930', 'abnormal tricuspid valve flow', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183859, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008403', 'decreased cellular sensitivity to alkylating agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183860, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003473', 'decreased summary potential threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183861, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183862, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006044', 'tricuspid valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183863, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008673', 'decreased interleukin-13 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183864, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002498', 'abnormal acute inflammation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183865, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010631', 'increased Q wave amplitude', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183866, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003823', 'increased left ventricle developed pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183867, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183868, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183869, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011805', 'decreased cell migration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183870, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012685', 'abnormal primitive streak elongation', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183871, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001999', 'photosensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183872, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011938', 'prolonged PP interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183873, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003741', 'tinnitus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183874, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003549', 'pulmonary hypotension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183875, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002999', 'abnormal bone healing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183876, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030575', 'decreased hair follicle cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183877, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001790', 'abnormal immune system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183878, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002842', 'increased systemic arterial blood pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183879, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003875', 'abnormal hair follicle regression', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183880, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006265', 'increased pulse pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183881, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008003', 'achlorhydria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183882, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010141', 'lymphangitis', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183883, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183884, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003698', 'abnormal male reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183885, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005004', 'abnormal lymphocyte anergy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183886, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001952', 'increased airway responsiveness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183887, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004244', 'abnormal miscarriage rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183888, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183889, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001924', 'infertility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183890, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000231', 'hypertension', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183891, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008678', 'increased interleukin-16 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183892, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010636', 'bundle branch block', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183893, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183894, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014034', 'abnormal submucosal gland secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183895, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010095', 'increased chromosomal stability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183896, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006046', 'atrioventricular valve regurgitation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183897, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003674', 'oxidative stress', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183898, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014046', 'abnormal mitophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183899, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183900, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009666', 'abnormal embryo attachment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183901, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031192', 'coronary artery spasm', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183902, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183903, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001917', 'intraventricular hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183904, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011718', 'decreased interleukin-8 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183905, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004212', 'abnormal salty taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183906, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003438', 'abnormal carotid body physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183907, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011937', 'shortened PP interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183908, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008747', 'abnormal T cell anergy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183909, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183910, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008652', 'decreased interleukin-1 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183911, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004046', 'abnormal mitosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183912, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013171', 'ear hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183913, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008690', 'increased interleukin-23 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183914, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030938', 'abnormal reticulophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183915, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008663', 'increased interleukin-12 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183916, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010394', 'decreased QRS amplitude', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183917, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183918, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010392', 'prolonged QRS complex duration', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183919, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183920, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031156', 'large intestine hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183921, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183922, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031484', 'increased urine hypoxanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183923, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003762', 'abnormal immune organ physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183924, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183925, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010377', 'abnormal gut flora balance', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183926, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013641', 'increased vertebra stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183927, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005087', 'decreased acute inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183928, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000743', 'muscle spasm', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183929, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006150', 'double vision', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183930, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003256', 'biliary cirrhosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183931, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031302', 'syncope', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183932, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011444', 'abnormal renal water homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183933, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030132', 'periodontium inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183934, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010515', 'abnormal Q wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183935, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010368', 'abnormal lymphatic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183936, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008543', 'atrial fibrillation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183937, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031124', 'aortic valve inflammation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183938, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001947', 'abnormal mucociliary clearance', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183939, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001619', 'abnormal vascular permeability', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183940, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031091', 'hypogeusia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183941, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183942, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001629', 'abnormal heart rate', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183943, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183944, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004185', 'abnormal adipocyte glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183945, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010512', 'absent PR interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183946, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008670', 'decreased interleukin-12b secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183947, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183948, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183949, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183950, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183951, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011420', 'pyuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183952, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011967', 'increased or absent threshold for auditory brainstem response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183953, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002327', 'abnormal respiratory function', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183954, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020363', 'abnormal germ cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183955, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008709', 'decreased interleukin-7 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183956, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011809', 'abnormal anoikis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183957, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005576', 'decreased pulmonary ventilation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183958, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183959, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183960, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020345', 'abnormal myocardial fiber currents', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183961, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031152', 'subcutaneous hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183962, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005258', 'ocular hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183963, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001671', 'abnormal vitamin absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183964, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010155', 'abnormal intestine physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183965, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183966, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183967, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010038', 'abnormal placenta physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183968, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008406', 'increased cellular sensitivity to hydrogen peroxide', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183969, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010895', 'increased lung compliance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183970, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006080', 'brain ischemia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183971, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010741', 'abnormal melanocyte proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183972, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020414', 'abnormal fibroblast physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183973, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004486', 'decreased response of heart to induced stress', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183974, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183975, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183976, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183977, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000350', 'abnormal cell proliferation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183978, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004766', 'decreased susceptibility to age-related hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183979, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183980, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009057', 'increased interleukin-21 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183981, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030797', 'joint laxity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183982, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012197', 'impaired myofibroblast differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183983, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001951', 'abnormal breathing pattern', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183984, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183985, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010951', 'abnormal lipid oxidation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183986, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012018', 'abnormal oviduct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183987, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183988, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006109', 'fibrillation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183989, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004130', 'abnormal muscle cell glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183990, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004145', 'abnormal muscle electrophysiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183991, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001914', 'hemorrhage', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(183992, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009046', 'muscle twitch', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183993, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002896', 'abnormal bone mineralization', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183994, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012565', 'perivasculitis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183995, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013210', 'abnormal primary cilium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183996, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183997, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004143', 'muscle hypertonia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183998, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(183999, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002796', 'impaired skin barrier function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184000, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014275', 'increased respiration', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184001, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030619', 'homogentisic aciduria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184002, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005647', 'abnormal sex gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184003, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012011', 'febrile seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184004, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002090', 'abnormal vision', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184005, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002500', 'granulomatous inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184006, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003471', 'abnormal summary potential threshold', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184007, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021054', 'increased renal arterial blood pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184008, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008271', 'abnormal bone ossification', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184009, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002328', 'abnormal airway resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184010, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031469', 'abnormal pinocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184011, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031480', 'abnormal urine xanthine level', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184012, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184013, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009667', 'abnormal embryo invasion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184014, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184015, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013638', 'decreased femur stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184016, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012699', 'decreased maternal body weight gain', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184017, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005411', 'delayed fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184018, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011046', 'abnormal lung tissue damping', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184019, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011706', 'abnormal fibroblast migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184020, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184021, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008001', 'hypochlorhydria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184022, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031481', 'decreased urine xanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184023, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010634', 'increased QRS amplitude', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184024, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003412', 'abnormal afterhyperpolarization', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184025, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184026, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184027, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030216', 'tongue muscle fasciculation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184028, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003699', 'abnormal female reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184029, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184030, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003548', 'pulmonary hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184031, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008676', 'decreased interleukin-15 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184032, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5454545454545454, 5.059610039003922, 1.6612607543676396, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184033, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184034, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013136', 'genital discharge', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184035, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006273', 'abnormal urine organic cation level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184036, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011925', 'abnormal heart echocardiography feature', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184037, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184038, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011702', 'abnormal fibroblast proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184039, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001666', 'abnormal intestinal absorption', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184040, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013559', 'abnormal exocrine gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184041, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003122', 'maternal imprinting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184042, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020381', 'muscle gating pore current', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184043, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000948', 'nonconvulsive seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184044, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000233', 'abnormal blood flow velocity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184045, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011194', 'abnormal hair follicle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184046, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010855', 'pulmonary hyperemia', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184047, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010514', 'fragmented QRS complex', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184048, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021016', 'decreased tau protein phosphorylation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184049, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184050, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002330', 'abnormal bronchial provocation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184051, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008995', 'early reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184052, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184053, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184054, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184055, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184056, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012125', 'decreased bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184057, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020317', 'abnormal vascular endothelial cell adhesion', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184058, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184059, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006110', 'ventricular fibrillation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184060, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009247', 'meteorism', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184061, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004587', 'decreased cellular sensitivity to X-ray irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184062, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003464', 'abnormal single cell response threshold', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184063, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001945', 'bronchoconstriction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184064, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184065, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184066, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003100', 'myopia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184067, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002335', 'decreased airway responsiveness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184068, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003260', 'vomiting', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184069, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031130', 'right-to-left shunt', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184070, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003034', 'increased pulmonary vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184071, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012305', 'umbilical cord hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184072, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030153', 'dental pulp inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184073, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011047', 'increased lung tissue damping', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184074, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003777', 'lip inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184075, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031306', 'abnormal cartilage physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184076, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012045', 'increased susceptibility to hypertension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184077, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001948', 'vesicoureteral reflux', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184078, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184079, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184080, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006048', 'pulmonary valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184081, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020219', 'increased tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184082, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005531', 'increased renal vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184083, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011255', 'abnormal anterior visceral endoderm cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184084, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184085, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011951', 'increased cardiac stroke volume', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184086, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184087, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020846', 'abnormal cell motility', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184088, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184089, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005043', 'defective assembly of class II molecules', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184090, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010507', 'shortened RR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184091, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184092, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003433', 'decreased activity of parathyroid', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184093, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008006', 'increased stomach pH', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184094, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012698', 'increased maternal body weight gain', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184095, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012111', 'failure of morula compaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184096, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012382', 'abnormal blood cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184097, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004759', 'decreased mitotic index', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184098, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006047', 'aortic valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184099, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009007', 'short estrous cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184100, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008861', 'abnormal hair shedding', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184101, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009062', 'impaired lectin complement pathway', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184102, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011467', 'decreased urine urea nitrogen level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184103, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001761', 'abnormal urination pattern', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184104, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184105, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014240', 'abnormal ribosome physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184106, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010752', 'impaired mucociliary clearance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184107, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006002', 'abnormal small intestinal transit time', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184108, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020439', 'absent b-wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184109, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009013', 'abnormal proestrus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184110, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002296', 'aspiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184111, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005598', 'decreased ventricle muscle contractility', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184112, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002128', 'abnormal blood circulation', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184113, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001846', 'increased inflammatory response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184114, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001665', 'chronic diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184115, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011397', 'endoneurial edema', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184116, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013285', 'abnormal renal filtration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184117, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010749', 'absent visual evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184118, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014031', 'abnormal submucosal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184119, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008669', 'increased interleukin-12b secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184120, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011417', 'abnormal renal transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184121, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003123', 'paternal imprinting', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184122, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012120', 'trophectoderm cell degeneration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184123, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030909', 'abnormal melanocyte adhesion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184124, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184125, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011927', 'abnormal cardiac valve flow', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184126, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008651', 'increased interleukin-1 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184127, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008007', 'abnormal cellular replicative senescence', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184128, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013971', 'blood in lymph vessels', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184129, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002195', 'psychomotor seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184130, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008005', 'decreased stomach pH', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184131, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031126', 'gangrene', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184132, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184133, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005591', 'decreased vasodilation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184134, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012037', 'abnormal b-wave latency', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184135, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184136, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184137, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003469', 'decreased single cell response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184138, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001648', 'abnormal apoptosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184139, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008402', 'increased cellular sensitivity to alkylating agents', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184140, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030940', 'impaired autophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184141, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002626', 'increased heart rate', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184142, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001856', 'myocarditis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184143, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008666', 'increased interleukin-12a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184144, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003725', 'increased autoantibody level', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184145, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031222', 'decreased CXCL10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184146, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012241', 'abnormal hepatoblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184147, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003659', 'abnormal lymph circulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184148, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010695', 'abnormal blood pressure regulation', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184149, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003925', 'abnormal cellular glucose uptake', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184150, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004925', 'decreased susceptibility to noise-induced hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184151, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184152, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003293', 'rectal hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184153, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004597', 'increased susceptibility to noise-induced hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184154, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006138', 'congestive heart failure', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184155, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003900', 'shortened QT interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184156, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184157, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008675', 'increased interleukin-15 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184158, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004742', 'abnormal vestibular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184159, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002694', 'abnormal pancreas secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184160, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013208', 'abnormal cilium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184161, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031013', 'abnormal egg activation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184162, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184163, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004022', 'abnormal cone electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184164, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008272', 'abnormal endochondral bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184165, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184166, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003470', 'abnormal summary potential', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184167, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010028', 'aciduria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184168, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184169, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009856', 'failure of ejaculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184170, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184171, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003172', 'abnormal lysosome physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184172, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184173, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184174, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184175, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030941', 'enhanced autophagy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184176, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020352', 'abnormal endoplasmic reticulum physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184177, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006112', 'angina', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184178, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008943', 'increased sensitivity to induced cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184179, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003233', 'prolonged QT interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184180, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005666', 'abnormal adipose tissue physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184181, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012039', 'abnormal b-wave implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184182, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013438', 'dysmyelination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184183, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003465', 'increased single cell response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184184, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006051', 'brainstem hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184185, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008679', 'decreased interleukin-16 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184186, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184187, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008069', 'abnormal joint mobility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184188, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011804', 'increased cell migration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184189, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010896', 'decreased lung compliance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184190, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184191, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001857', 'pericarditis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184192, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010504', 'abnormal RR interval', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184193, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012697', 'abnormal maternal body weight gain', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184194, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005342', 'abnormal intestinal lipid absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184195, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008661', 'decreased interleukin-10 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184196, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184197, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011832', 'abnormal visual acuity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184198, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020961', 'abnormal c-wave amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184199, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008404', 'increased cellular sensitivity to methylmethanesulfonate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184200, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001950', 'abnormal respiratory sounds', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184201, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010994', 'aerophagia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184202, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004743', 'abnormal vestibular evoked myogenic potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184203, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014182', 'decreased respiratory epithelial sodium ion transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184204, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031092', 'dysgeusia', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184205, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184206, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001864', 'vascular inflammation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184207, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003038', 'decreased myocardial infarct size', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184208, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004512', 'anosmia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184209, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004175', 'telangiectases', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184210, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184211, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003926', 'decreased cellular glucose uptake', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184212, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014029', 'increased respiratory epithelial chloride transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184213, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005590', 'increased vasodilation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184214, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013639', 'decreased bone stiffness', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184215, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005253', 'abnormal eye physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184216, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010560', 'intraventricular block', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184217, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001760', 'abnormal urine enzyme level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184218, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010571', 'shortened ST segment', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184219, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009698', 'heart hemorrhage', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184220, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003502', 'increased activity of thyroid gland', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184221, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002419', 'abnormal innate immunity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184222, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002499', 'chronic inflammation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184223, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184224, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184225, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031051', 'lymph node hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184226, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010946', 'hyperpnea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184227, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184228, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020096', 'high mean heart rate adaptation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184229, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004003', 'abnormal vascular endothelial cell physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184230, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003878', 'abnormal ear physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184231, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012556', 'increased cell death', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184232, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184233, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031129', 'left-to-right shunt', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184234, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005572', 'abnormal pulmonary respiratory rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184235, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008866', 'chromosomal instability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184236, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009668', 'ectopic pregnancy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184237, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003866', 'abnormal defecation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184238, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001921', 'reduced fertility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184239, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020958', 'abnormal c-wave implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184240, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003077', 'abnormal cell cycle', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184241, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001739', 'abnormal adrenal gland secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184242, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184243, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184244, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184245, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014120', 'focal seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184246, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009016', 'abnormal estrus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184247, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001379', 'abnormal penile erection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184248, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014202', 'abnormal intestinal epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184249, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001533', 'abnormal skeleton physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184250, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184251, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004513', 'avnosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184252, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013503', 'abnormal embryonic tissue cell apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184253, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004945', 'abnormal bone resorption', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184254, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004213', 'abnormal umami taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184255, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020155', 'enhanced humoral immune response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184256, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184257, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184258, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009009', 'absent estrous cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184259, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008748', 'abnormal central T cell anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184260, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003896', 'prolonged PR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184261, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184262, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008814', 'decreased nerve conduction velocity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184263, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005435', 'hemoperitoneum', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184264, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005000', 'abnormal immune tolerance', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184265, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003482', 'increased nerve fiber response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184266, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004760', 'increased mitotic index', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184267, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184268, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001636', 'irregular heartbeat', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184269, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184270, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000304', 'abnormal cardiac stroke volume', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184271, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010381', 'abnormal dosage compensation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184272, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001916', 'intracerebral hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184273, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184274, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020847', 'abnormal peroxisome physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184275, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005600', 'increased ventricle muscle contractility', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184276, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011968', 'decreased threshold for auditory brainstem response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184277, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004012', 'increased pulmonary artery pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184278, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031424', 'enhanced female fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184279, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004086', 'absent heartbeat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184280, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006049', 'semilunar valve regurgitation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184281, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008567', 'decreased interferon-gamma secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184282, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184283, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006153', 'hypermetropia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184284, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012555', 'decreased cell death', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184285, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031170', 'abnormal vasculature physiology', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184286, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002322', 'abnormal respiratory transport', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184287, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004014', 'abnormal uterine environment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184288, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030982', 'abnormal copulatory plug deposition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184289, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002410', 'decreased susceptibility to viral infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184290, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020001', 'decreased response to antigen', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184291, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184292, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002473', 'impaired complement classical pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184293, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184294, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001923', 'reduced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184295, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004780', 'abnormal surfactant secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184296, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004738', 'abnormal auditory brainstem response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184297, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020860', 'abnormal cornea physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184298, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011952', 'decreased cardiac stroke volume', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184299, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001954', 'respiratory distress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184300, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002578', 'impaired ability to fire action potentials', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184301, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003261', 'hematemesis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184302, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011044', 'increased lung elastance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184303, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002338', 'abnormal pulmonary ventilation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184304, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003566', 'abnormal cell adhesion', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184305, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031433', 'decreased miscarriage rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184306, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5454545454545454, 5.059610039003922, 1.6612607543676396, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184307, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003259', 'nausea', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184308, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011825', 'decreased cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184309, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184310, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009662', 'abnormal uterine receptivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184311, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184312, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002294', 'short gestation period', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184313, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009661', 'abnormal pregnancy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184314, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184315, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003868', 'abnormal feces composition', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184316, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184317, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011928', 'abnormal mitral valve flow', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184318, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003298', 'choking', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184319, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004070', 'abnormal P wave', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184320, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184321, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031153', 'stomach hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184322, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184323, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002161', 'abnormal fertility/fecundity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184324, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011221', 'decreased intestinal calcium absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184325, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184326, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012746', 'abnormal neural crest cell delamination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184327, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000610', 'cholestasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184328, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008708', 'increased interleukin-7 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184329, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184330, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184331, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013752', 'stridor', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184332, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020147', 'abnormal defecation amount', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184333, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001712', 'abnormal placenta development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184334, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184335, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004216', 'salt-resistant hypertension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184336, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008008', 'early cellular replicative senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184337, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002334', 'abnormal airway responsiveness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184338, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008942', 'abnormal induced cell death', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184339, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004796', 'increased anti-histone antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184340, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004051', 'increased renal sympathetic nerve activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184341, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012201', 'decreased endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184342, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004211', 'abnormal sour taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184343, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184344, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010552', 'abnormal HV interval', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184345, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184346, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010954', 'abnormal cellular respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184347, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184348, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010993', 'decreased surfactant secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184349, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031104', 'crackles', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184350, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003468', 'increased single cell response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184351, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184352, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012554', 'increased serum complement activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184353, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003393', 'decreased cardiac output', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184354, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004879', 'decreased systemic vascular resistance', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184355, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184356, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184357, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184358, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184359, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009665', 'abnormal embryo apposition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184360, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002164', 'abnormal gland physiology', 0.5454545454545454, 5.059610039003922, 1.6612607543676396, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184361, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020978', 'abnormal FO-wave implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184362, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184363, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184364, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010559', 'heart block', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184365, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011442', 'abnormal renal sodium ion transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184366, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005671', 'abnormal response to transplant', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184367, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184368, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006384', 'enhanced cochlear frequency tuning', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184369, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003889', 'enhanced sensorimotor gating', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184370, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004829', 'increased anti-chromatin antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184371, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184372, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004859', 'abnormal synaptic plasticity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184373, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010071', 'abnormal pruritus', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184374, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004484', 'abnormal response of heart to induced stress', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184375, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184376, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184377, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008568', 'abnormal interleukin secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184378, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009019', 'abnormal metestrus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184379, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005530', 'decreased renal vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184380, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004036', 'abnormal muscle relaxation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184381, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031105', 'rhonchi', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184382, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184383, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000064', 'failure of bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184384, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010513', 'abnormal ventricular activation time', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184385, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008684', 'increased interleukin-18 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184386, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030144', 'abnormal facial muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184387, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184388, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009006', 'prolonged estrous cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184389, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031118', 'cardiovalvulitis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184390, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012124', 'increased bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184391, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002471', 'abnormal complement pathway', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184392, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011048', 'decreased lung tissue damping', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184393, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003480', 'increased nerve fiber response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184394, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012032', 'abnormal ERG latency', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184395, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184396, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031128', 'cardiovascular shunt', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184397, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009344', 'abnormal ovulation cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184398, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003221', 'abnormal cardiomyocyte apoptosis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184399, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184400, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010094', 'abnormal chromosome stability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184401, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184402, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002314', 'abnormal respiratory mechanics', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184403, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009349', 'increased urine pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184404, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006114', 'cardiac murmur', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184405, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008711', 'increased interleukin-9 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184406, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001800', 'abnormal humoral immune response', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184407, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008409', 'increased cellular sensitivity to hydroxyurea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184408, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184409, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004966', 'abnormal inner cell mass proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184410, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184411, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003394', 'increased cardiac output', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184412, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184413, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000061', 'fragile skeleton', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184414, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184415, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184416, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005575', 'increased pulmonary ventilation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184417, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004265', 'abnormal placental transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184418, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184419, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008685', 'decreased interleukin-18 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184420, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011518', 'abnormal cell chemotaxis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184421, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013145', 'eye discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184422, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003416', 'premature bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184423, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012038', 'abnormal a-wave implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184424, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010050', 'hypermyelination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184425, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003071', 'decreased vascular permeability', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184426, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031086', 'wheezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184427, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020002', 'increased response to antigen', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184428, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006054', 'spinal hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184429, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031117', 'subdural hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184430, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184431, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011421', 'cylindruria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184432, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001985', 'abnormal gustatory system physiology', 0.5454545454545454, 5.059610039003922, 1.6612607543676396, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184433, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002472', 'impaired complement alternative pathway', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184434, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184435, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008877', 'abnormal DNA methylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184436, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005076', 'abnormal cell differentiation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184437, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008694', 'decreased interleukin-23a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184438, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001378', 'abnormal ejaculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184439, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184440, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001845', 'abnormal inflammatory response', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184441, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006060', 'increased cerebral infarct size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184442, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008565', 'decreased interferon-beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184443, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184444, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031102', 'rhinorrhea', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184445, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009876', 'increased cellular sensitivity to thiophosphamide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184446, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009353', 'twin decidual capsule', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184447, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000503', 'excessive digestive secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184448, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184449, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184450, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011437', 'glomerulus hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184451, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011431', 'increased urine flow rate', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184452, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001613', 'abnormal vasodilation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184453, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184454, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002779', 'abnormal sex gland secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184455, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184456, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009352', 'impaired spacing of implantation sites', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184457, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184458, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184459, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004009', 'abnormal diastolic filling velocity', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184460, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001542', 'abnormal bone strength', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184461, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001598', 'abnormal blood viscosity', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184462, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001839', 'abnormal level of surface class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184463, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013555', 'abnormal apocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184464, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002007', 'increased cellular sensitivity to gamma-irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184465, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004736', 'abnormal distortion product otoacoustic emission', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184466, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184467, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008840', 'abnormal spike wave discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184468, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003880', 'abnormal central pattern generator function', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184469, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013806', 'encephalopathy', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184470, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011824', 'increased cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184471, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031471', 'abnormal micropinocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184472, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011918', 'abnormal PQ interval', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184473, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184474, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008775', 'abnormal heart ventricle pressure', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184475, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184476, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008950', 'ventricular tachycardia', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184477, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184478, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001983', 'abnormal olfactory system physiology', 0.5454545454545454, 5.059610039003922, 1.6612607543676396, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184479, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009645', 'crystalluria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184480, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184481, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001919', 'abnormal reproductive system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184482, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001837', 'defective assembly of class I molecules', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184483, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006149', 'decreased visual acuity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184484, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013561', 'abnormal endocrine gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184485, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010516', 'absent Q wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184486, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184487, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002907', 'abnormal parturition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184488, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011953', 'prolonged PQ interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184489, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184490, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184491, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003193', 'decreased cholesterol efflux', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184492, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008004', 'abnormal stomach pH', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184493, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005245', 'hemarthrosis', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184494, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005595', 'abnormal vascular smooth muscle physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184495, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005257', 'abnormal intraocular pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184496, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003431', 'abnormal parathyroid gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184497, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009045', 'muscle tetany', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184498, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184499, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011082', 'abnormal gastrointestinal motility', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184500, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184501, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008405', 'decreased cellular sensitivity to methylmethanesulfonate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184502, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003501', 'iodide oxidation defect', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184503, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002841', 'impaired skeletal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184504, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009562', 'abnormal odor adaptation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184505, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020974', 'abnormal FO-wave shape', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184506, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005645', 'abnormal hypothalamus physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184507, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184508, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184509, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002987', 'abnormal urine osmolality', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184510, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011994', 'increased nerve conduction velocity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184511, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003432', 'increased activity of parathyroid', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184512, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000951', 'sporadic seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184513, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030798', 'joint contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184514, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003252', 'abnormal bile duct physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184515, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.6666666666666666, 8.605269980670606, 2.3951715290935645, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184516, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010334', 'pleural effusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184517, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184518, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184519, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001963', 'abnormal hearing physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184520, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184521, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030215', 'facial muscle fasciculation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184522, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184523, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000316', 'cellular necrosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184524, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004142', 'abnormal muscle tone', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184525, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003996', 'clonic seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184526, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008682', 'decreased interleukin-17 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184527, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001933', 'abnormal litter size', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184528, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184529, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184530, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002409', 'decreased susceptibility to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184531, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011717', 'increased interleukin-8 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184532, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003280', 'urinary incontinence', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184533, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021015', 'increased tau protein phosphorylation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184534, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011919', 'abnormal R wave', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184535, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184536, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005399', 'increased susceptibility to fungal infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184537, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013627', 'increased vertebra yield load', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184538, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009275', 'bruising', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184539, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031425', 'enhanced male fertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184540, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184541, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004752', 'decreased length of allograft survival', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184542, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012031', 'abnormal b-wave amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184543, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.6363636363636364, 8.605269980670606, 2.3401027534683996, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184544, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031009', 'abnormal sperm-egg fusion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184545, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000920', 'abnormal myelination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184546, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006152', 'tunnel vision', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184547, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005364', 'increased susceptibility to prion infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184548, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008687', 'increased interleukin-2 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184549, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010950', 'abnormal lung hysteresivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184550, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008260', 'abnormal autophagy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184551, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008566', 'increased interferon-gamma secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184552, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004773', 'abnormal bile composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184553, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002106', 'abnormal muscle physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184554, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003192', 'increased cholesterol efflux', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184555, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020848', 'abnormal exocytosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184556, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031402', 'decreased muscle fatigability', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184557, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001793', 'abnormal susceptibility to infection', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184558, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184559, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004021', 'abnormal rod electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184560, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001663', 'abnormal digestive system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184561, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010935', 'increased airway resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184562, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184563, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005620', 'abnormal muscle contractility', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184564, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030574', 'increased hair follicle cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184565, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031127', 'dry gangrene', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184566, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012036', 'abnormal a-wave latency', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184567, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012010', 'parturition failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184568, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184569, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012115', 'abnormal trophectoderm cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184570, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005037', 'mucous diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184571, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031169', 'abnormal joint physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184572, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184573, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005036', 'diarrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184574, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030129', 'tongue inflammation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184575, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013134', 'poor circulation in autopods', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184576, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003633', 'abnormal nervous system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184577, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030933', 'hyphema', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184578, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014037', 'stranguria', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184579, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020412', 'abnormal amnion physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184580, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020842', 'abnormal supporting cell of carotid body physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184581, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003621', 'dysuria', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184582, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184583, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184584, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003865', 'lymph node inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184585, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010570', 'prolonged ST segment', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184586, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003820', 'increased left ventricle systolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184587, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184588, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001863', 'blood vessel inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184589, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004745', 'absent vestibular evoked myogenic potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184590, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184591, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009276', 'ecchymosis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184592, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013644', 'increased vertebra maximal load', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184593, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011900', 'podocyturia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184594, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003901', 'abnormal PR interval', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184595, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001499', 'abnormal kindling response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184596, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003037', 'increased myocardial infarct size', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184597, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014030', 'abnormal mucous gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184598, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005044', 'sepsis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184599, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005501', 'abnormal skin physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184600, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184601, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001943', 'abnormal respiration', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184602, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184603, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184604, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012030', 'abnormal a-wave amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184605, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000249', 'abnormal blood vessel physiology', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184606, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011966', 'abnormal auditory brainstem response waveform shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184607, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001599', 'abnormal blood volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184608, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001853', 'heart inflammation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184609, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014183', 'increased respiratory epithelial sodium ion transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184610, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020142', 'increased anti-sperm antibody level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184611, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184612, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031014', 'polyspermy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184613, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020154', 'impaired humoral immune response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184614, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010520', 'sinoatrial block', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184615, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008564', 'increased interferon-beta secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184616, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008672', 'increased interleukin-13 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184617, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020039', 'increased bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184618, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013632', 'increased femur maximal load', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184619, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006045', 'mitral valve regurgitation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184620, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184621, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004782', 'abnormal surfactant physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184622, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002876', 'abnormal thyroid gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184623, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008688', 'decreased interleukin-2 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184624, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184625, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184626, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003660', 'chylothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184627, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004156', 'abnormal QT variability', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184628, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010936', 'decreased airway resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184629, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000947', 'convulsive seizures', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184630, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013634', 'increased femur fracture load', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184631, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003466', 'decreased single cell response threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184632, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184633, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010386', 'abnormal urinary bladder physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184634, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012745', 'abnormal neural crest cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184635, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009567', 'mitotic nondisjunction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184636, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003463', 'abnormal single cell response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184637, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184638, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010957', 'abnormal aerobic respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184639, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005260', 'ocular hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184640, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030939', 'abnormal autophagosome formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184641, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008562', 'increased interferon-alpha secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184642, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008555', 'abnormal interferon secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184643, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184644, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184645, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003101', 'high myopia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184646, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013642', 'decreased vertebra stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184647, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184648, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004737', 'absent distortion product otoacoustic emissions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184649, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003216', 'absence seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184650, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004888', 'abnormal perilymph physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184651, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006383', 'abnormal cochlear frequency tuning', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184652, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008722', 'abnormal chemokine secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184653, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184654, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010510', 'absent P wave', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184655, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009358', 'environmentally induced seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184656, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008691', 'decreased interleukin-23 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184657, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184658, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010072', 'increased pruritus', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184659, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003096', 'increased corneal light-scattering', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184660, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004878', 'increased systemic vascular resistance', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184661, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030924', 'early exit from telogen phase', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184662, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184663, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011045', 'decreased lung elastance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184664, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020220', 'decreased tear production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184665, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005005', 'abnormal self tolerance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184666, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004558', 'delayed allantois development', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184667, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005085', 'abnormal gallbladder physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184668, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020138', 'delayed bone mineralization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184669, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184670, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012550', 'respiratory acidosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184671, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0021053', 'abnormal renal arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184672, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005363', 'decreased susceptibility to prion infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184673, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002136', 'abnormal kidney physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184674, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5454545454545454, 5.059610039003922, 1.6612607543676396, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184675, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011466', 'increased urine urea nitrogen level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184676, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003898', 'abnormal QRS complex', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184677, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002952', 'ventricular cardiomyopathy', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184678, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008712', 'decreased interleukin-9 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184679, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184680, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184681, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004072', 'abnormal frontal plane axis', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184682, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003472', 'increased summary potential threshold', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184683, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003824', 'decreased left ventricle developed pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184684, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011936', 'abnormal PP interval', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184685, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000352', 'decreased cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184686, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000427', 'abnormal hair cycle', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184687, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031483', 'decreased urine hypoxanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184688, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030988', 'dysosmia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184689, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020137', 'decreased bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184690, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003476', 'decreased summary potential intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184691, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003157', 'impaired muscle relaxation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184692, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012006', 'abnormal hippocampus physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184693, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184694, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001915', 'intracranial hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184695, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010143', 'enhanced fertility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184696, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001627', 'abnormal cardiac output', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184697, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011929', 'abnormal aortic valve flow', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184698, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004485', 'increased response of heart to induced stress', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184699, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184700, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008002', 'hyperchlorhydria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184701, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004071', 'prolonged P wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184702, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008700', 'decreased interleukin-4 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184703, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184704, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002635', 'reduced sensorimotor gating', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184705, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003928', 'increased heart rate variability', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184706, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020371', 'abnormal glymphatic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184707, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184708, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184709, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010511', 'shortened PR interval', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184710, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004514', 'dystocia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184711, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001934', 'increased litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184712, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000501', 'abnormal digestive secretion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184713, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008563', 'decreased interferon-alpha secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184714, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000505', 'decreased digestive secretion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184715, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012040', 'abnormal c-wave shape', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184716, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005333', 'decreased heart rate', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184717, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002998', 'abnormal bone remodeling', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184718, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005402', 'abnormal action potential', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184719, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184720, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0002406', 'increased susceptibility to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184721, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004037', 'increased muscle relaxation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184722, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003929', 'decreased heart rate variability', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184723, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030951', 'abnormal endocytosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184724, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001876', 'decreased inflammatory response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184725, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009058', 'decreased interleukin-21 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184726, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003415', 'priapism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184727, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008408', 'decreased cellular sensitivity to hydroxyurea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184728, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000351', 'increased cell proliferation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184729, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0000343', 'abnormal response to cardiac infarction', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184730, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184731, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006052', 'cerebellum hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184732, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008681', 'increased interleukin-17 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184733, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184734, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184735, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003547', 'abnormal pulmonary pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184736, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031098', 'abnormal sputum production', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184737, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020097', 'low mean heart rate adaptation', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184738, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008696', 'increased interleukin-3 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184739, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013468', 'chromodacryorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184740, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184741, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014157', 'alacrima', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184742, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008697', 'decreased interleukin-3 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184743, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010107', 'abnormal renal reabsorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184744, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184745, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011220', 'increased intestinal calcium absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184746, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184747, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003726', 'decreased autoantibody level', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184748, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031155', 'small intestine hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184749, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031162', 'abnormal vagina physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184750, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184751, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006332', 'abnormal cochlear potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184752, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004748', 'increased susceptibility to age-related hearing loss', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184753, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184754, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.6086956521739131, 8.605269980670606, 2.288665642468749, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184755, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5454545454545454, 5.059610039003922, 1.6612607543676396, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184756, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031090', 'ageusia', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184757, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020146', 'abnormal vascular endothelial cell proliferation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184758, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031080', 'pulmonary embolism', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184759, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011920', 'abnormal S wave', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184760, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184761, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003477', 'abnormal nerve fiber response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184762, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013557', 'abnormal merocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184763, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012035', 'abnormal b-wave shape', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184764, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0009384', 'cardiac valve regurgitation', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184765, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004217', 'salt-sensitive hypertension', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184766, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003009', 'abnormal cytokine secretion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184767, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005088', 'increased acute inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184768, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031066', 'cytokine storm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184769, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003070', 'increased vascular permeability', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184770, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004811', 'abnormal neuron physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184771, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001337', 'dry eyes', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184772, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184773, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005551', 'abnormal eye electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184774, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008693', 'increased interleukin-23a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184775, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184776, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184777, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0008706', 'decreased interleukin-6 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184778, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0013637', 'increased femur stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184779, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031154', 'intestinal hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184780, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184781, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012200', 'increased endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184782, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0006335', 'abnormal hearing electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184783, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014048', 'abnormal Peyers patch physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184784, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0003207', 'decreased cellular sensitivity to gamma-irradiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184785, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0031385', 'enhanced blood-brain barrier function', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(184786, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0010753', 'improved mucociliary clearance', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184787, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0030214', 'muscle fasciculation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184788, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011758', 'renal ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184789, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005042', 'abnormal level of surface class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184790, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184791, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0011722', 'abnormal ossification involved in bone maturation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184792, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0014190', 'abnormal epididymis physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184793, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0005414', 'extrahepatic cholestasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184794, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0001664', 'abnormal digestion', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184795, 'HP:0011025', 'Abnormal cardiovascular system physiology', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184796, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013331', 'abnormal lacrimal gland development', 0.42857142857142855, 12.906707549770184, 2.351902653759005, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184797, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0001346', 'abnormal lacrimal gland morphology', 0.4444444444444444, 12.906707549770184, 2.3950604306707013, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184798, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0006225', 'ocular rupture', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(184799, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013442', 'abnormal Harderian gland size', 0.41379310344827586, 9.175301480945878, 1.948506216278038, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(184800, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013472', 'abnormal lacrimal gland bud elongation', 0.42105263157894735, 12.906707549770184, 2.331180640544744, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184801, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013449', 'abnormal lacrimal lake morphology', 0.4117647058823529, 11.799792345853673, 2.2042545281258414, 'UPHENO:0088074', 'abnormal lacrimal apparatus morphology'),
(184802, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0014156', 'abnormal lacrimal gland myoepithelium morphology', 0.43636363636363634, 12.906707549770184, 2.3731872745107405, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184803, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013441', 'abnormal intraorbital lacrimal gland morphology', 0.42857142857142855, 12.906707549770184, 2.351902653759005, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184804, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0014147', 'lacrimal gland necrosis', 0.4307692307692308, 13.799792345853671, 2.4381398511157033, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(184805, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013440', 'abnormal exorbital lacrimal gland morphology', 0.42857142857142855, 12.906707549770184, 2.351902653759005, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184806, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013453', 'enlarged lacrimal gland', 0.4745762711864407, 13.799792345853671, 2.559111954300245, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(184807, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0014151', 'lacrimal gland hypoplasia', 0.4375, 13.799792345853671, 2.4571139882616313, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(184808, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013474', 'abnormal lacrimal gland branching morphogenesis', 0.42105263157894735, 12.906707549770184, 2.331180640544744, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184809, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0006209', 'calcified intraocular region', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(184810, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013455', 'lacrimal gland atrophy', 0.4666666666666667, 13.799792345853671, 2.5376964150054895, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(184811, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:3000005', 'abnormal lacrimal sac morphology', 0.43103448275862066, 12.906707549770184, 2.358651312261305, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184812, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0014148', 'lacrimal gland degeneration', 0.4827586206896552, 13.799792345853671, 2.581078983426888, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(184813, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.42, 11.799792345853673, 2.2261879492213907, 'UPHENO:0088074', 'abnormal lacrimal apparatus morphology'),
(184814, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013470', 'absent lacrimal gland bud', 0.41379310344827586, 12.906707549770184, 2.3109968784744597, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184815, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013454', 'lacrimal gland hypertrophy', 0.4444444444444444, 13.799792345853671, 2.4765381165250884, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(184816, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0002697', 'abnormal eye size', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(184817, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013473', 'ectopic lacrimal gland bud', 0.41379310344827586, 12.906707549770184, 2.3109968784744597, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184818, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013469', 'abnormal lacrimal gland bud morphology', 0.42105263157894735, 12.906707549770184, 2.331180640544744, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184819, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013471', 'small lacrimal gland bud', 0.41379310344827586, 12.906707549770184, 2.3109968784744597, 'UPHENO:0087575', 'abnormal lacrimal gland morphology'),
(184820, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0013451', 'nasolacrimal duct obstruction', 0.44642857142857145, 12.607147267911277, 2.372380817786902, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(184821, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0014150', 'lacrimal gland hyperplasia', 0.45161290322580644, 13.799792345853671, 2.4964303085053743, 'UPHENO:0020995', 'abnormal lacrimal gland morphology'),
(184822, 'HP:0011482', 'Abnormal lacrimal gland morphology', 'MP:0008969', 'abnormal nasolacrimal duct morphology', 0.4230769230769231, 12.607147267911277, 2.309500611579382, 'UPHENO:0076731', 'abnormal lacrimal drainage system morphology'),
(184823, 'HP:0410331', 'Nut food product allergy', 'MP:0000392', 'accelerated hair follicle regression', 0.41025641025641024, 8.297292005324488, 1.8449978951081858, 'UPHENO:0054970', 'increased biological_process'),
(184824, 'HP:0410331', 'Nut food product allergy', 'MP:0001790', 'abnormal immune system physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184825, 'HP:0008462', 'Cervical instability', 'MP:0000071', 'axial skeleton hypoplasia', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(184826, 'HP:0008462', 'Cervical instability', 'MP:0004610', 'small vertebrae', 0.425, 8.052558416233639, 1.8499560337746668, 'UPHENO:0002813', 'abnormal vertebral column'),
(184827, 'HP:0008462', 'Cervical instability', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.40540540540540543, 8.052558416233639, 1.8068067714296148, 'UPHENO:0002813', 'abnormal vertebral column'),
(184828, 'HP:0008462', 'Cervical instability', 'MP:0004703', 'abnormal vertebral column morphology', 0.42424242424242425, 8.052558416233639, 1.8483064961896052, 'UPHENO:0002813', 'abnormal vertebral column'),
(184829, 'HP:0008462', 'Cervical instability', 'MP:0021136', 'abnormal vertebrae shape', 0.4146341463414634, 8.052558416233639, 1.8272563270597264, 'UPHENO:0002813', 'abnormal vertebral column'),
(184830, 'HP:0008462', 'Cervical instability', 'MP:0031313', 'spondylolisthesis', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(184831, 'HP:0008462', 'Cervical instability', 'MP:0010104', 'enlarged thoracic cage', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(184832, 'HP:0008462', 'Cervical instability', 'MP:0010103', 'small thoracic cage', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(184833, 'HP:0008462', 'Cervical instability', 'MP:0004174', 'abnormal spine curvature', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(184834, 'HP:0008462', 'Cervical instability', 'MP:0006322', 'abnormal perichondrium morphology', 0.4411764705882353, 4.825104621810128, 1.4590142656153757, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(184835, 'HP:0008462', 'Cervical instability', 'MP:0004669', 'enlarged vertebral body', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(184836, 'HP:0008462', 'Cervical instability', 'MP:0004675', 'rib fractures', 0.41025641025641024, 6.976576768886775, 1.691799438787516, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(184837, 'HP:0008462', 'Cervical instability', 'MP:0003200', 'calcified joint', 0.4166666666666667, 4.825104621810128, 1.4179069994493834, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(184838, 'HP:0008462', 'Cervical instability', 'MP:0004704', 'short vertebral column', 0.4146341463414634, 8.052558416233639, 1.8272563270597264, 'UPHENO:0002813', 'abnormal vertebral column'),
(184839, 'HP:0008462', 'Cervical instability', 'MP:0031312', 'spondylolysis', 0.4117647058823529, 8.052558416233639, 1.8209226638879836, 'UPHENO:0002813', 'abnormal vertebral column'),
(184840, 'HP:0008462', 'Cervical instability', 'MP:0002114', 'abnormal axial skeleton morphology', 0.41935483870967744, 6.976576768886775, 1.7104564378148297, 'UPHENO:0087089', 'abnormal axial skeleton plus cranial skeleton morphology'),
(184841, 'HP:0008462', 'Cervical instability', 'MP:0013844', 'abnormal perichondrial ossification', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(184842, 'HP:0008462', 'Cervical instability', 'MP:0008771', 'elongated vertebral column', 0.4146341463414634, 8.052558416233639, 1.8272563270597264, 'UPHENO:0002813', 'abnormal vertebral column'),
(184843, 'HP:0008462', 'Cervical instability', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.40476190476190477, 8.052558416233639, 1.8053722283122766, 'UPHENO:0002813', 'abnormal vertebral column'),
(184844, 'HP:0032470', 'Monilethrix', 'MP:0010202', 'focal dorsal hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184845, 'HP:0032470', 'Monilethrix', 'MP:0000402', 'abnormal zigzag hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(184846, 'HP:0032470', 'Monilethrix', 'MP:0013117', 'focal hair loss in thorax region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184847, 'HP:0032470', 'Monilethrix', 'MP:0009934', 'abnormal hind foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184848, 'HP:0032470', 'Monilethrix', 'MP:0009004', 'progressive hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(184849, 'HP:0032470', 'Monilethrix', 'MP:0000411', 'shiny fur', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(184850, 'HP:0032470', 'Monilethrix', 'MP:0012076', 'abnormal agouti pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184851, 'HP:0032470', 'Monilethrix', 'MP:0030584', 'skin atrophy', 0.40540540540540543, 6.904974582545727, 1.6731150647672055, 'UPHENO:0003811', 'abnormal skin of body'),
(184852, 'HP:0032470', 'Monilethrix', 'MP:0001511', 'disheveled coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(184853, 'HP:0032470', 'Monilethrix', 'MP:0008237', 'abnormal ventral coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184854, 'HP:0032470', 'Monilethrix', 'MP:0005409', 'darkened coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(184855, 'HP:0032470', 'Monilethrix', 'MP:0001211', 'wrinkled skin', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(184856, 'HP:0032470', 'Monilethrix', 'MP:0008899', 'plush coat', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(184857, 'HP:0032470', 'Monilethrix', 'MP:0000397', 'abnormal guard hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(184858, 'HP:0032470', 'Monilethrix', 'MP:0000400', 'abnormal awl hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(184859, 'HP:0032470', 'Monilethrix', 'MP:0001510', 'abnormal coat appearance', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(184860, 'HP:0032470', 'Monilethrix', 'MP:0002671', 'belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184861, 'HP:0032470', 'Monilethrix', 'MP:0008238', 'abnormal dorsoventral coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184862, 'HP:0032470', 'Monilethrix', 'MP:0002073', 'abnormal hair growth', 0.4411764705882353, 9.570057949176055, 2.0547711282141323, 'UPHENO:0002768', 'abnormal strand of hair'),
(184863, 'HP:0032470', 'Monilethrix', 'MP:0000426', 'ectopic hair growth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(184864, 'HP:0032470', 'Monilethrix', 'MP:0010142', 'disorganized hair shaft', 0.4186046511627907, 9.570057949176055, 2.0015171169446777, 'UPHENO:0002768', 'abnormal strand of hair'),
(184865, 'HP:0032470', 'Monilethrix', 'MP:0013115', 'focal hair loss in abdominal region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184866, 'HP:0032470', 'Monilethrix', 'MP:0000373', 'belly spot', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(184867, 'HP:0032470', 'Monilethrix', 'MP:0009928', 'abnormal pinna hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184868, 'HP:0032470', 'Monilethrix', 'MP:0010203', 'focal ventral hair loss', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184869, 'HP:0032470', 'Monilethrix', 'MP:0002938', 'white spotting', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184870, 'HP:0032470', 'Monilethrix', 'MP:0000418', 'focal hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(184871, 'HP:0032470', 'Monilethrix', 'MP:0001197', 'oily skin', 0.4166666666666667, 6.904974582545727, 1.6961936041405727, 'UPHENO:0003811', 'abnormal skin of body'),
(184872, 'HP:0032470', 'Monilethrix', 'MP:0009933', 'abnormal tail hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184873, 'HP:0032470', 'Monilethrix', 'MP:0004034', 'belly blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184874, 'HP:0032470', 'Monilethrix', 'MP:0008812', 'abnormal rostrocaudal coat patterning', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184875, 'HP:0032470', 'Monilethrix', 'MP:0005366', 'variegated coat color', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(184876, 'HP:0032470', 'Monilethrix', 'MP:0013116', 'focal hair loss in head/neck region', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184877, 'HP:0032470', 'Monilethrix', 'MP:0009002', 'premature hair regrowth', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(184878, 'HP:0032470', 'Monilethrix', 'MP:0005114', 'premature hair loss', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(184879, 'HP:0032470', 'Monilethrix', 'MP:0003196', 'calcified skin', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(184880, 'HP:0032470', 'Monilethrix', 'MP:0000370', 'head blaze', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184881, 'HP:0032470', 'Monilethrix', 'MP:0000405', 'abnormal auchene hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(184882, 'HP:0032470', 'Monilethrix', 'MP:0000372', 'irregular coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184883, 'HP:0032470', 'Monilethrix', 'MP:0009932', 'skin fibrosis', 0.4411764705882353, 6.904974582545727, 1.7453688194272856, 'UPHENO:0003811', 'abnormal skin of body'),
(184884, 'HP:0032470', 'Monilethrix', 'MP:0005171', 'absent coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184885, 'HP:0032470', 'Monilethrix', 'MP:0000407', 'abnormal duvet hair morphology', 0.45454545454545453, 9.570057949176055, 2.0856716761116956, 'UPHENO:0002768', 'abnormal strand of hair'),
(184886, 'HP:0032470', 'Monilethrix', 'MP:0009659', 'striated fur', 0.41025641025641024, 9.570057949176055, 1.9814584578473484, 'UPHENO:0002768', 'abnormal strand of hair'),
(184887, 'HP:0032470', 'Monilethrix', 'MP:0020235', 'black belted', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184888, 'HP:0032470', 'Monilethrix', 'MP:0000371', 'diluted coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184889, 'HP:0032470', 'Monilethrix', 'MP:0012017', 'grizzled coat color', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184890, 'HP:0032470', 'Monilethrix', 'MP:0002075', 'abnormal coat/hair pigmentation', 0.42857142857142855, 9.570057949176055, 2.0252045345568774, 'UPHENO:0002768', 'abnormal strand of hair'),
(184891, 'HP:0032470', 'Monilethrix', 'MP:0003956', 'abnormal body size', 0.40625, 3.067140347159989, 1.1162552423320329, 'UPHENO:0015280', 'abnormal anatomical entity morphology in the independent continuant'),
(184892, 'HP:0032470', 'Monilethrix', 'MP:0002940', 'variable body spotting', 0.40540540540540543, 9.570057949176055, 1.9697089182513596, 'UPHENO:0002768', 'abnormal strand of hair'),
(184893, 'HP:0032470', 'Monilethrix', 'MP:0011280', 'abnormal flank coat pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184894, 'HP:0032470', 'Monilethrix', 'MP:0000367', 'abnormal coat/ hair morphology', 0.4838709677419355, 9.570057949176055, 2.1518999050174754, 'UPHENO:0002768', 'abnormal strand of hair'),
(184895, 'HP:0032470', 'Monilethrix', 'MP:0020440', 'abnormal front foot hair pigmentation', 0.4166666666666667, 9.570057949176055, 1.996878600588935, 'UPHENO:0002768', 'abnormal strand of hair'),
(184896, 'HP:0032470', 'Monilethrix', 'MP:0003849', 'greasy coat', 0.4090909090909091, 9.570057949176055, 1.9786418843441866, 'UPHENO:0002768', 'abnormal strand of hair'),
(184897, 'HP:0030760', 'Renal fibrosis', 'MP:0031002', 'abnormal kidney glycogen level', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184898, 'HP:0030760', 'Renal fibrosis', 'MP:0009641', 'kidney degeneration', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184899, 'HP:0030760', 'Renal fibrosis', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184900, 'HP:0030760', 'Renal fibrosis', 'MP:0012025', 'abnormal comma shaped body morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184901, 'HP:0030760', 'Renal fibrosis', 'MP:0003881', 'abnormal nephron morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184902, 'HP:0030760', 'Renal fibrosis', 'MP:0011843', 'abnormal kidney collecting duct epithelium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184903, 'HP:0030760', 'Renal fibrosis', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184904, 'HP:0030760', 'Renal fibrosis', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4444444444444444, 7.390401409715969, 1.8123528488577088, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184905, 'HP:0030760', 'Renal fibrosis', 'MP:0011331', 'abnormal papillary duct morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184906, 'HP:0030760', 'Renal fibrosis', 'MP:0009860', 'nephrosclerosis', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184907, 'HP:0030760', 'Renal fibrosis', 'MP:0004969', 'pale kidney', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184908, 'HP:0030760', 'Renal fibrosis', 'MP:0002955', 'increased compensatory renal growth', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184909, 'HP:0030760', 'Renal fibrosis', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184910, 'HP:0030760', 'Renal fibrosis', 'MP:0005360', 'urolithiasis', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184911, 'HP:0030760', 'Renal fibrosis', 'MP:0012024', 'abnormal nephron morphogenesis', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184912, 'HP:0030760', 'Renal fibrosis', 'MP:0003672', 'abnormal ureter development', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184913, 'HP:0030760', 'Renal fibrosis', 'MP:0003014', 'abnormal kidney medulla morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184914, 'HP:0030760', 'Renal fibrosis', 'MP:0008528', 'polycystic kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184915, 'HP:0030760', 'Renal fibrosis', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184916, 'HP:0030760', 'Renal fibrosis', 'MP:0009640', 'abnormal renal tubule epithelium morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184917, 'HP:0030760', 'Renal fibrosis', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184918, 'HP:0030760', 'Renal fibrosis', 'MP:0011767', 'ureterocele', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184919, 'HP:0030760', 'Renal fibrosis', 'MP:0011402', 'renal cast', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184920, 'HP:0030760', 'Renal fibrosis', 'MP:0002706', 'abnormal kidney size', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184921, 'HP:0030760', 'Renal fibrosis', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184922, 'HP:0030760', 'Renal fibrosis', 'MP:0002707', 'abnormal kidney weight', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184923, 'HP:0030760', 'Renal fibrosis', 'MP:0012026', 'abnormal S-shaped body morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184924, 'HP:0030760', 'Renal fibrosis', 'MP:0004195', 'abnormal kidney calyx morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184925, 'HP:0030760', 'Renal fibrosis', 'MP:0003600', 'ectopic kidney', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184926, 'HP:0030760', 'Renal fibrosis', 'MP:0011364', 'abnormal metanephros morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184927, 'HP:0030760', 'Renal fibrosis', 'MP:0003826', 'abnormal Mullerian duct morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184928, 'HP:0030760', 'Renal fibrosis', 'MP:0003605', 'fused kidneys', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184929, 'HP:0030760', 'Renal fibrosis', 'MP:0003197', 'nephrocalcinosis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184930, 'HP:0030760', 'Renal fibrosis', 'MP:0000521', 'abnormal kidney cortex morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184931, 'HP:0030760', 'Renal fibrosis', 'MP:0011383', 'abnormal kidney capsule morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184932, 'HP:0030760', 'Renal fibrosis', 'MP:0003985', 'renal fibrosis', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184933, 'HP:0030760', 'Renal fibrosis', 'MP:0011381', 'abnormal kidney lobe morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184934, 'HP:0030760', 'Renal fibrosis', 'MP:0004755', 'abnormal loop of Henle morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184935, 'HP:0030760', 'Renal fibrosis', 'MP:0000530', 'abnormal kidney vasculature morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184936, 'HP:0030760', 'Renal fibrosis', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184937, 'HP:0030760', 'Renal fibrosis', 'MP:0000534', 'abnormal ureter morphology', 0.43333333333333335, 7.390401409715969, 1.7895550501573252, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184938, 'HP:0030760', 'Renal fibrosis', 'MP:0002956', 'decreased compensatory renal growth', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184939, 'HP:0030760', 'Renal fibrosis', 'MP:0008487', 'abnormal mesonephros morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184940, 'HP:0030760', 'Renal fibrosis', 'MP:0011797', 'blind ureter', 0.41935483870967744, 7.390401409715969, 1.7604546546762325, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184941, 'HP:0030760', 'Renal fibrosis', 'MP:0003613', 'abnormal kidney medulla development', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184942, 'HP:0030760', 'Renal fibrosis', 'MP:0011361', 'pelvic kidney', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184943, 'HP:0030760', 'Renal fibrosis', 'MP:0011534', 'granular kidney', 0.5172413793103449, 7.667568053596582, 1.9914777116498774, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184944, 'HP:0030760', 'Renal fibrosis', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184945, 'HP:0030760', 'Renal fibrosis', 'MP:0002135', 'abnormal kidney morphology', 0.5357142857142857, 7.667568053596582, 2.0267278413734213, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184946, 'HP:0030760', 'Renal fibrosis', 'MP:0000527', 'abnormal kidney development', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184947, 'HP:0030760', 'Renal fibrosis', 'MP:0002703', 'abnormal renal tubule morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184948, 'HP:0030760', 'Renal fibrosis', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184949, 'HP:0030760', 'Renal fibrosis', 'MP:0011382', 'abnormal kidney lobule morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184950, 'HP:0030760', 'Renal fibrosis', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184951, 'HP:0030760', 'Renal fibrosis', 'MP:0011487', 'abnormal ureteropelvic junction morphology', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184952, 'HP:0030760', 'Renal fibrosis', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184953, 'HP:0030760', 'Renal fibrosis', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184954, 'HP:0030760', 'Renal fibrosis', 'MP:0003675', 'kidney cyst', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184955, 'HP:0030760', 'Renal fibrosis', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184956, 'HP:0030760', 'Renal fibrosis', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184957, 'HP:0030760', 'Renal fibrosis', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184958, 'HP:0030760', 'Renal fibrosis', 'MP:0011488', 'abnormal ureterovesical junction morphology', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184959, 'HP:0030760', 'Renal fibrosis', 'MP:0002708', 'nephrolithiasis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(184960, 'HP:0030760', 'Renal fibrosis', 'MP:0003942', 'abnormal urinary system development', 0.42857142857142855, 7.390401409715969, 1.7796951676841382, 'UPHENO:0087427', 'abnormal renal system morphology'),
(184961, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184962, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184963, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184964, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184965, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184966, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184967, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184968, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184969, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184970, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184971, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184972, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184973, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184974, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184975, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184976, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184977, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184978, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184979, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184980, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184981, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184982, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184983, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184984, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184985, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184986, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184987, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184988, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184989, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184990, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184991, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184992, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184993, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184994, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(184995, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184996, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184997, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184998, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(184999, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185000, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185001, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185002, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185003, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185004, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185005, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185006, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185007, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185008, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185009, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185010, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185011, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185012, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185013, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185014, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185015, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185016, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185017, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185018, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185019, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185020, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185021, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185022, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185023, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185024, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185025, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185026, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185027, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185028, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185029, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185030, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185031, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185032, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185033, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185034, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185035, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185036, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185037, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185038, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185039, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185040, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185041, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185042, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185043, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185044, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185045, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185046, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185047, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185048, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185049, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185050, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185051, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185052, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185053, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185054, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185055, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185056, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185057, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185058, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185059, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185060, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185061, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185062, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185063, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185064, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185065, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185066, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185067, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185068, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185069, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185070, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185071, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185072, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185073, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185074, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185075, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185076, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185077, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185078, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185079, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185080, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185081, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185082, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185083, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185084, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185085, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185086, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185087, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185088, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185089, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185090, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185091, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185092, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185093, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185094, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185095, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185096, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185097, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185098, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185099, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185100, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185101, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185102, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185103, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185104, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185105, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185106, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185107, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185108, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185109, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185110, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185111, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185112, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185113, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185114, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185115, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185116, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185117, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185118, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185119, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185120, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185121, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185122, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185123, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185124, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185125, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185126, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185127, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185128, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185129, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185130, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185131, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185132, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185133, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185134, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185135, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185136, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185137, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185138, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185139, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185140, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185141, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185142, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185143, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185144, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185145, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185146, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185147, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185148, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185149, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185150, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185151, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185152, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185153, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185154, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185155, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185156, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185157, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185158, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185159, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185160, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185161, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185162, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185163, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185164, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185165, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185166, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185167, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185168, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185169, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185170, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185171, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185172, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185173, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185174, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185175, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185176, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185177, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185178, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185179, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185180, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185181, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185182, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185183, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185184, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185185, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185186, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185187, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185188, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185189, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185190, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185191, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185192, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185193, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185194, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185195, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185196, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185197, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185198, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185199, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185200, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185201, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185202, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185203, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185204, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185205, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185206, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185207, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185208, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185209, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185210, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185211, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185212, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185213, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185214, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185215, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185216, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185217, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185218, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185219, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185220, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185221, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185222, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185223, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185224, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185225, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185226, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185227, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185228, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185229, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185230, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185231, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185232, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185233, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185234, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185235, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185236, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185237, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185238, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185239, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185240, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185241, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185242, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185243, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185244, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185245, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185246, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185247, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185248, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185249, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185250, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185251, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185252, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185253, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185254, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185255, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185256, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185257, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185258, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185259, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185260, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185261, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185262, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185263, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185264, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185265, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185266, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185267, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185268, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185269, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185270, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185271, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185272, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185273, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185274, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185275, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185276, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185277, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185278, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185279, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185280, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185281, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185282, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185283, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185284, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185285, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185286, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185287, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185288, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185289, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185290, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185291, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185292, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185293, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185294, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185295, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185296, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185297, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185298, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185299, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185300, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185301, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185302, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185303, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185304, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185305, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185306, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185307, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185308, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185309, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185310, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185311, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185312, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185313, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185314, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185315, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185316, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185317, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185318, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185319, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185320, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185321, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185322, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185323, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185324, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185325, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185326, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185327, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185328, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185329, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185330, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185331, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185332, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185333, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185334, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185335, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185336, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185337, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185338, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185339, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185340, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185341, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185342, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185343, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185344, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185345, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185346, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185347, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185348, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185349, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185350, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185351, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185352, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185353, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185354, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185355, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185356, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185357, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185358, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185359, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185360, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185361, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185362, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185363, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185364, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185365, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185366, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185367, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185368, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185369, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185370, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185371, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185372, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185373, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185374, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185375, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185376, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185377, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185378, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185379, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185380, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185381, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185382, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185383, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185384, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185385, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185386, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185387, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185388, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185389, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185390, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185391, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185392, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185393, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185394, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185395, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185396, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185397, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185398, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185399, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185400, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185401, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185402, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185403, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185404, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185405, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185406, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185407, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185408, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185409, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185410, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185411, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185412, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185413, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185414, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185415, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185416, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185417, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185418, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185419, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185420, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185421, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185422, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185423, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185424, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185425, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185426, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185427, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185428, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185429, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185430, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185431, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185432, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185433, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185434, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185435, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185436, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185437, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185438, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185439, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185440, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185441, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185442, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185443, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185444, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185445, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185446, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185447, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185448, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185449, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185450, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185451, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185452, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185453, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185454, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185455, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185456, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185457, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185458, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185459, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185460, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185461, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185462, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185463, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185464, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185465, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185466, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185467, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185468, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185469, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185470, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185471, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185472, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185473, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185474, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185475, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185476, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185477, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185478, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185479, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185480, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185481, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185482, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185483, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185484, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185485, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185486, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185487, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185488, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185489, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185490, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185491, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185492, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185493, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185494, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185495, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185496, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185497, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185498, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185499, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185500, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185501, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185502, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185503, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185504, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185505, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185506, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185507, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185508, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185509, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185510, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185511, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185512, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185513, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185514, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185515, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185516, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185517, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185518, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185519, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185520, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185521, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185522, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185523, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185524, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185525, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185526, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185527, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185528, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185529, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185530, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185531, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185532, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185533, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185534, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185535, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185536, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185537, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185538, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185539, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185540, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185541, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185542, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185543, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185544, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185545, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185546, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185547, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185548, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185549, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185550, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185551, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185552, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185553, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185554, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185555, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185556, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185557, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185558, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185559, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185560, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185561, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185562, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185563, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185564, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185565, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185566, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185567, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185568, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185569, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185570, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185571, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185572, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185573, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185574, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185575, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185576, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185577, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185578, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185579, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185580, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185581, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185582, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185583, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185584, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185585, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185586, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185587, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185588, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185589, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185590, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185591, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185592, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185593, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185594, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185595, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185596, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185597, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185598, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185599, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185600, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185601, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185602, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185603, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185604, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185605, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185606, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185607, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185608, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185609, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185610, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185611, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185612, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185613, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185614, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185615, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185616, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185617, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185618, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185619, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185620, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(185621, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185622, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185623, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185624, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185625, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(185626, 'HP:0033562', 'Anti-glycoprotein-210 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
